We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Monday
May 15
15:00 - 16:00
Stolz 1
Biomarkers
Jan Bussink, The Netherlands;
Shing Fung Lee, Singapore
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.
Mini-Oral
Clinical
15:00 - 16:00
The impact of the ADC for the early prediction of treatment response after definitive radiotherapy
Cem Onal, Turkey
MO-0869
15:00 - 16:00
HPV subtypes and integration not prognostic in p16+ oropharyngeal squamous cell carcinoma
Jacob Lilja-Fischer, Denmark
MO-0870
15:00 - 16:00
HPV DNA in plasma and oral gargle from patients with HPV oropharyngeal cancer treated with radiation
Michelle Echevarria, USA
MO-0871
15:00 - 16:00
Circulating tumor cells and efficacy of prostate bed salvage radiotherapy combined with abiraterone
Stephane Supiot, France
MO-0872
15:00 - 16:00
Rapid increase in ctDNA at commencement of curative-intent radiotherapy for NSCLC
Michael MacManus, Australia
MO-0873
15:00 - 16:00
Nutritional and inflammatory status as biomarkers in oligorecurrent PCa (RADIOSA TRIAL): an update
Mattia Zaffaroni, Italy
MO-0874
15:00 - 16:00
Sarcopenia - a prognostic biomarker for definitive chemoradiotherapy in oesophageal cancer patients
Alan McWilliam, United Kingdom
MO-0875
15:00 - 16:00
BIOGUIDE-X: A First-in-Human Study of the Performance and Safety of Biology-Guided Radiotherapy
Lucas Vitzthum, USA
MO-0876